The novel treatment elritercept received a Fast Track designation from the FDA to treat anemia in patients with MDS. For patients with lower-risk myelodysplastic syndromes (MDS), the Food and Drug ...
Those who regularly donate blood can develop anemia – the most common type of iron deficiency, which happens when your blood has fewer red blood cells or less hemoglobin than normal. Hemoglobin is a ...
WATERTOWN, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...
Diamond-Blackfan anemia is a rare blood disorder that is present from birth. It can cause symptoms of anemia, physical changes, and other health issues. Treatment may include blood transfusions, ...
NX-5948 has received fast track designation for relapsed or refractory Waldenström macroglobulinemia after prior BTK inhibitor therapy. The phase 1a/1b trial of NX-5948 shows a 77.8% objective ...
Akebia Therapeutics will not start a proposed trial for its anemia treatment after meeting with the Food and Drug Administration. The biopharmaceutical company said Tuesday it believes regulatory ...
If you’re undergoing treatment for anemia, it’s understandable to wonder about the signs iron pills are working. After all, these are very different from run-of-the-mill supplements, and it’s ...
A patient on Long Island is the first in New York to be cured of sickle cell anemia, doctors say. They credit state-of-the-art genetic treatment. Medical history made at Cohen Children's Medical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback